Nurix Therapeutics (NRIX) Q1 2025 Earnings

28JanConfirmed
Q1 2024
Q3 2024
Q4 2024
Q1 2025
-0.78
-0.73
-0.68
-0.63

Details

Expected EPS
-0.686097
Actual EPS
-0.75
Surprise EPS
-0.06
Surprise Percent
+9.31%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.75 per share for Q1 2025.

0 Comments

Share your thoughts